The $140,672,343 man: Why does Brent Saunders have the richest golden parachute in biopharma?
Live by the deal, profit by the deal.
If any company can succeed where Pfizer failed and take over Allergan, CEO Brent Saunders may be …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
